MDsim has developed SPINEsim, an AI-driven digital twin platform that creates patient-specific biomechanical models of the spine. Using advanced Computer Modeling & Simulation (CM&S) technology, SPINEsim enables healthcare professionals to analyse spinal mechanics, prevent disease progression, and personalise treatments.
Unlike traditional imaging methods like X-rays, CT scans, and MRIs, which provide static snapshots, SPINEsim offers dynamic, predictive insights into how the spine behaves under different conditions. By integrating AI, biomechanics, and clinical data, it bridges the gap between research and real-world spine care, allowing for more precise and effective medical decisions.
Addressing a critical need in spine care
Back pain affects up to 80% of people at some point in their lives, with conditions like osteoporosis, scoliosis, and degenerative disc disease leading to chronic pain and disability. Over 2 million spinal fusion surgeries are performed annually, yet 15–35% of these procedures fail, requiring costly and complex revision surgeries. The lack of personalised, data-driven planning tools has made spine care a major challenge—until now.
SPINEsim empowers healthcare professionals to move beyond conventional trial-and-error approaches. By simulating different treatment scenarios before intervention, it improves patient outcomes, enhances surgical precision, and reduces complications.
A certified medical solution
SPINEsim is not just a research tool, it is a Software as a Medical Device (SaMD) that meets strict regulatory standards. Designed for clinical use, it integrates seamlessly into hospital systems, spine care centers, and surgical planning workflows, providing a practical and scalable solution for specialists.
Industry partnerships and market growth
MDsim is partnering with leading institutions to drive the adoption of SPINEsim. Collaborations with Centre Hospitalier Universitaire de Lille, Fondation Hopale, and Hexagon are helping validate the technology and integrate AI-powered digital twins into routine clinical practice. These partnerships are key to optimising surgical planning, improving patient outcomes, and advancing precision spine care.
With the global spine care market projected to exceed $10 billion, the demand for more accurate, non-invasive, and cost-effective solutions is rapidly increasing. MDsim’s scalable, AI-driven technology positions it as a key player in the future of spine care.
Why invest in MDSim?
MDsim combines medical expertise, cutting-edge artificial intelligence, and a strong market need to drive meaningful change in spinal care. By investing in this project, you are supporting a revolutionary technology that improves patient care, reduces healthcare costs, and sets new standards for precision medicine in spinal treatment.
So far, we have raised €1.7 million in our SEED round, covering the objectives for SPINEsim development, obtaining regulatory certification, and expanding into the U.S. and EU markets. Now, we are raising an additional €250,000 with Capital Cell to bring on investors and industry professionals who wish to become strategic partners in our growth.
Join us in shaping the future of spinal care, where treatments are smarter, surgeries are safer, and patient outcomes are better than ever.
